Season 25 Episode 140
Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making.
CME information and select publications here.
Published on 1 week, 2 days ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate